1 company and 1 research report found for "Argos Therapeutics"
No sector reports have been found.
Encouraging Phase II survival data at ASCO for Argos's lead product AGS-003 in mRCC have failed to move the stock from levels close to its 52-week low...
Forgotten your login?
Registered office: Edison Investment Research Limited, 280 High Holborn, London, WC1V 7EE UK. Company no. 4794244. VAT no. 815041270
© 2017 All rights reserved. Edison Investment Research is authorised and regulated by the Financial Conduct Authority.
This site requires cookies in order to give you the best user experience.
Find out more